Rearch homepage new banner Nov 2013

AstraZeneca is a global biopharmaceutical company with research and development at its core

Our expertise research and development spans the entire life-cycle of a medicine. We have capabilities in both small molecules and biologics. This allows us to search for solutions to unmet medical needs using both modalities, individually or in combination


Horizon Discovery & AstraZeneca: Searching for novel, personalised cancer therapies

An IMED Collaboration Update

At AstraZeneca, our bold ambition is to transform the lives of people with cancer and one day help to eliminate cancer as a cause of death. A joint project plan agreed with Horizon Discovery, a Cambridge, UK-based translational genomics company, is ensuring that innovation is at the forefront of our collaboration. Our partnership uses cutting-edge science to develop advanced approaches to the treatment of cancer through a better understanding of the genetic basis of the disease.

Download collaboration update (PDF 384kb)
 

View more collaboration updates
 


Our leaders iconOur leaders

All Directors are collectively responsible for the success of AstraZeneca. Discover general information,  images and biographies of our Board of Directors.

Read more


Pipeline iconOur pipeline

AstraZeneca's pipeline is one of the most exciting in the industry. Download the latest version of our development pipeline.

Read more


Path to meds iconPath to new medicines

The discovery, development and commercialisation of a medicine is a complex process. Information on our path to new medicines and an interactive overview are available.

Read more


Neuro iconAZ Neuroscience

Visit our dedicated neuroscience site for more information on our research and partnering in the area.

 

Visit site


Open innovation iconOpen innovation

Visit our Open Innovation site to see how we collaborate to push the boundaries of science and deliver life-changing medicines

Visit site


LabTalk is AstraZeneca’s science-focused blog where you can hear from scientists, researchers and academics discussing novel ideas, research and innovation.

The_PARP_THM 19 December 2014

The PARP inhibitor paradigm: a collaborative approach to cancer drug discovery

Targeting_escape_THM 10 December 2014

Targeting escape pathways to further personalise breast cancer treatment

Accelerating_THM 8 December 2014

Accelerating drug discovery for brain disorders – a partnership model